Jm. Zapata et al., EXPRESSION OF MULTIPLE APOPTOSIS-REGULATORY GENES IN HUMAN BREAST-CANCER CELL-LINES AND PRIMARY TUMORS, Breast cancer research and treatment, 47(2), 1998, pp. 129-140
The expression of several apoptosis-regulating genes was evaluated in
9 human breast cancer cell lines, 2 immortalized human mammary epithel
ial lines, 1 normal breast tissue biopsy, and 3 primary breast tumors,
using a multiple antigen detection (MAD) immunoblotting method. The a
nti-apoptotic proteins Bcl-2, Bcl-X-L, Mcl-1, and BAG-1 were present a
t immunodetectable levels in 7, 10, 10, and 9 of the 11 lines. Compari
ng these 11 cell lines among themselves revealed that steady-state lev
els of Bcl-2, Bcl-X-L, Mcl-1, and BAG-1 were present at relatively hig
her levels in 4, 6, 5, and 5 of the lines, respectively. In contrast,
the pro-apoptotic proteins Bar and Bak were detected in all 11 cell li
nes, and were present at relatively higher levels in 10 and 5 of the 1
1 lines, respectively. The Interleukin-1 beta converting enzyme (ICE)
homolog CPP32 (Caspase-3) was expressed in 10/11 breast cell lines. Hi
gh levels of p53 protein, indicative of mutant p53, were found in 8 of
the 11 lines and correlated inversely with Bar expression (p = 0.01).
Bcl-2 and BAG-1 protein levels were positively correlated (p = 0.03).
Immunoblot analysis of primary adenocarcinomas revealed expression of
the antiapoptotic proteins Bcl-2, Bcl-X-L, Mcl-1, and BAG-1, as well
as the pro-apoptotic proteins Bar, Bak, and CPP32, in at least 2 of th
e 3 tumors examined. Immunohistochemical analysis was also performed f
or all of these proteins using 20 paraffin-embedded breast cancer biop
sy specimens that all contained residual normal mammary epithelium in
combination with both invasive cancer and carcinoma in situ. All of th
ese apoptosisregulating proteins were detected in primary breast cance
rs, though the percentage of immunopositive tumor cells varied widely
in some cases. Comparisons of the intensity of immunostaining in norma
l mammary epithelium and invasive carcinoma suggested that Bcl-2 immun
ointensity tends to be lower in cancers than normal breast epithelium
(p = 0.03), whereas CPP32 immunointensity was generally higher in inva
sive cancers (p < 0.0001). Taken together, the results demonstrate exp
ression of multiple apoptosis-modulating proteins in breast cancer cel
l lines and primary tumors, suggesting complexity in the regulation of
apoptosis in these neoplasms of mammary epithelial origin.